Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
about
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung DiseaseDiagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' PerspectivesUnderstanding nontuberculous mycobacterial lung disease: it's been a long time comingPulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New InsightsUpdate in Tuberculosis/Pulmonary Infections 2015Down-Regulation of Serum High-Mobility Group Box 1 Protein in Patients with Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease.Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model.Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung DiseaseAssociation of ISMav6 with the Pattern of Antibiotic Resistance in Korean Mycobacterium avium Clinical Isolates but No Relevance between Their Genotypes and Clinical Features.Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Broncho-Pleural Fistula with Hydropneumothorax at CT: Diagnostic Implications in Mycobacterium avium Complex Lung Disease with Pleural InvolvementPeak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung DiseaseClinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung DiseaseClinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung DiseaseAttenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes.Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.Antibiotic treatment for nontuberculous mycobacterial lung disease.Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.[Nontuberculous mycobacterial pulmonary disease].Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.New insights in the treatment of nontuberculous mycobacterial pulmonary disease.[Nontuberculous mycobacteria in sputum : Recommendations for diagnosis and treatment].Macrolide-Resistant Mycobacterium avium Complex: "I Feel Like I've Been Here Before".MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease
P2860
Q26748674-C3CAE4E6-AF84-4277-A335-D7BB8198DDFAQ26749480-9E21110C-4A13-4D78-BD72-17F82826DEB3Q28071355-64F2BC48-0278-456D-949E-0CC73A7327FAQ28087593-2CFEEC31-FC0E-4B82-9E75-28F7EE2ED473Q28387739-A7846E1B-9928-4427-A985-796C8EAB481FQ33567357-A4CA8E73-621A-466F-B21A-850793205703Q35127708-80F8C18F-B98C-4D12-9B4C-E55E98599CFDQ35787739-7AB3AF32-0B0D-49A1-B7C6-E4529A117AEEQ35797447-19049724-0C0E-4B6E-BA4D-206BDA1DEF02Q35859886-37E79857-179C-4EFB-8521-3933BDC75E04Q35918281-CC2D6F9C-3A48-4EB2-A7F6-52969442377EQ36344023-32107DB9-C40F-440A-AE47-0E0F8A7C3F0FQ36567746-5E7AB771-7DA6-419C-BDF5-DE56B1B143A2Q36660739-580B2BC0-AA5D-4909-85BD-240B4F1AD357Q37287653-F5A0C314-0AD6-432C-9985-27D572481BD8Q37358685-E7824EAD-60D5-4B2D-B9E4-CBFEB04C7577Q37613058-B9F838DB-A33A-40E0-AD30-58EAC95E57E6Q37627857-F550E0B7-47F3-4093-85CB-B92AD34E3FC9Q38581888-4AC25AF0-A937-4386-89DD-19A4C484FD48Q38770072-9DB10C10-ECD7-4B49-944F-4423516BCFC8Q39500615-4DF2F0EF-080A-4901-BDCB-4D25D8AC7A62Q40100000-C2880BF3-DDB5-4BCE-BD12-6753B464F188Q40818353-170893E1-B0DD-4AC6-BE35-ED73CC263E82Q41996865-DDF71928-FCC1-4AF3-87BC-3A65C20A6A55Q46248419-4915EDA5-75FD-4FAB-94B9-B937B3A2A490Q47127168-1FBCC026-E7E7-43B2-A8AD-D279CE8D222FQ47917686-9DAECFB8-DD07-4B16-9EC1-C7A898884173Q50077778-7785806D-3542-406C-8840-A6094E01046DQ52817516-B4D9331E-CB83-4E3C-9509-C61F154D0C9DQ57210549-6C6BEBA9-409C-47B1-83A2-AE940B78F9FA
P2860
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intermittent antibiotic therap ...... um avium complex lung disease.
@en
type
label
Intermittent antibiotic therap ...... um avium complex lung disease.
@en
prefLabel
Intermittent antibiotic therap ...... um avium complex lung disease.
@en
P2093
P2860
P50
P1476
Intermittent antibiotic therap ...... um avium complex lung disease.
@en
P2093
Charles L Daley
Hye Yun Park
Kyeongman Jeon
Kyung Soo Lee
Nam Yong Lee
Su-Young Kim
Sung Jae Shin
Won-Jung Koh
P2860
P304
P356
10.1164/RCCM.201408-1545OC
P407
P577
2015-01-01T00:00:00Z